Stocks
Bristol-Myers (BMY) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 6.66% | -23.8% | 19.5% | 20.4% | 27.3% | -42.3% | ||
| Changes by years, y/y, % | -29pp | -30pp | +43pp | +1pp | +7pp | -5.0% | |||
Bristol-Myers. ROE, %
Bristol-Myers. ROE, changes, pp
Bristol-Myers (BMY) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | 28.6% | 27.3% | -37.3% | -38.4% | -42.3% | -42.3% | |
| Changes by years, y/y, % | +8pp | +7pp | -60pp | -63pp | -71pp | |||
| Changes by quarters, q/q, % | +4pp | -1pp | -65pp | -1pp | -4pp | |||
